Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
The 340B Drug Pricing Program is a federally funded program that allows certain hospitals and clinics (“covered entities”) that serve many uninsured and low-income patients to buy prescription drugs directly from drug manufacturers at a much lower cost.
We, the undersigned organizations, collectively represent a diverse community of individuals including patients, survivors, and caregivers who are impacted by cancer and other complex conditions including autoimmune, cardiovascular, gastrointestinal, and rheumatological illnesses. We are focused on bringing together patients and their loved ones, advocates, and policy experts to ensure that the patient voice plays an integral role in federal and state policymaking impacting health care access, patient experiences, and patient outcomes.
Group letter encouraging CMS to extend the 10-digit claims processing screens policy to community settings to ensure timely reimbursement and allow physicians to choose the best care site for their patients without billing constraints
Group letter urging Congress to permanently extend the ACA’s enhanced advance premium tax credits (APTCs) before they expire at the end of 2025
Group letter to Congressional leadership supporting passage of the Safe Step Act in any final PBM reform or end-of-year legislative package.
Sign-on letter commenting on the principal illness navigation (PIN) provisions of the CY 2025 CMS Physician Fee Schedule (PFS) proposed rule.
Group letter to CMS and HHS commenting on CMS' CY 2025 Physician Fee Schedule (PFS) Principle Illness Navigation provisions
Group letter to CMS commenting on the CY 2025 MPFS Proposed Rule regarding caregiver training services
Group letter commenting on the FY2025 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems (OPPS) proposed rule, with the goal of increasing access to safe CAR T therapy in outpatient settings
Organization sign-on letter to Congressional leadership, urging them to prioritize a patient-centered approach when considering and advancing health care legislation to ensure that patient, survivor, and caregiver perspectives are incorporated in conversations about policies that stand to impact them the most.